Please Wait
Applying Filters...
menu
    • menu

    Annual Sales of Pharmakon1600-01500137 reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

    Client Email Product
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Pharmakon1600-01500137

    ACTIVE PHARMA INGREDIENTS

    PRICE INFORMATION

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 884Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 5Madopar

    PharmaCompass
    Left Arrow
    Right Arrow
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Madopar

    Benserazide

    arrow
    34th IFSCC
    Not Confirmed

    Brand Name : Madopar

    Switzerland
    arrow
    34th IFSCC
    Not Confirmed

    Roche

    Benserazide

    Main Therapeutic Indication : CNS & Anesthesia

    Currency : USD

    2019 Revenue in Millions : 378

    2018 Revenue in Millions : 351

    Growth (%) : 8

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Madopar

    Benserazide

    arrow
    34th IFSCC
    Not Confirmed

    Brand Name : Madopar

    Switzerland
    arrow
    34th IFSCC
    Not Confirmed

    Roche

    Benserazide

    Main Therapeutic Indication : CNS & Anesthesia

    Currency : USD

    2020 Revenue in Millions : 402

    2019 Revenue in Millions : 409

    Growth (%) : -2

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Madopar

    Levodopa and Benserazide

    arrow
    34th IFSCC
    Not Confirmed

    Brand Name : Madopar

    Switzerland
    arrow
    34th IFSCC
    Not Confirmed

    Roche

    Levodopa and Benserazide

    Main Therapeutic Indication : Neurology

    Currency : USD

    2021 Revenue in Millions : 424

    2020 Revenue in Millions : 383

    Growth (%) : 9

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Madopar

    Benserazide

    arrow
    34th IFSCC
    Not Confirmed

    Brand Name : Madopar

    Switzerland
    arrow
    34th IFSCC
    Not Confirmed

    Roche

    Benserazide

    Main Therapeutic Indication : Neurology

    Currency : USD

    2022 Revenue in Millions : 414

    2021 Revenue in Millions : 424

    Growth (%) : -2

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Madopar

    Benserazide

    arrow
    34th IFSCC
    Not Confirmed

    Brand Name : Madopar

    Switzerland
    arrow
    34th IFSCC
    Not Confirmed

    Roche

    Benserazide

    Main Therapeutic Indication : Neurology

    Currency : USD

    2023 Revenue in Millions : 412

    2022 Revenue in Millions : 414

    Growth (%) : -6

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF